Page 239 - Mployee Wellness Programs News Today

With the money, Daye is looking to reach more people with its products and services, whether that’s in the U.S., U.K. or Europe, Milanova said. The company will also expand research in gynecological health, focusing on conditions like endometriosis, PCOS and menopause. 

A patient affected by a data breach at Advocate Aurora Health has sued the healthcare system in a class-action lawsuit, claiming his private information was shared with Facebook in a breach that could have affected three million patients. The patient is alleging that the patient portal he used to communicate with his doctors at Advocate Aurora and to schedule appointments used a pixelated code that also enabled logging in via Facebook and then shared data with Facebook. “Whenever a patient us...

Indiana University Health has begun working with healthcare technology company TRIMEDX to test the security of connected medical devices at the health system’s medical device security lab. At the lab, IU Health and TRIMEDX will focus on testing new devices, configurations and security settings, as well as actively scanning medical equipment for security vulnerabilities.

Large employers, particularly self-insured companies, can demand a better and fairer system. They can use their contracting power to insist that their plans cover all FDA approved drugs.

Cresilon, a startup that makes a hemostatic gel to stop bleeding, has raised $25 million in a Series A-4 financing round. The round brings the company's total funding to date to nearly $82 million. The funds will help support Cresilon's entrance into the human health market, as its gel is currently used only by veterinarians.

As digital health gains popularity, the survey provides payers and other healthcare stakeholders with key information on consumers’ preferences when it comes to virtual primary care.

Voice-enabled technology powered by AI reduces documentation time by several hours per week, but physicians won’t adopt a solution unless it’s affordable and intuitive.

The settlement terms are still being negotiated and the final settlement depends on the number of states, counties, and Native American tribes that agree to join

Alkermes says separating cancer from its portfolio and pipeline of neuroscience products could put the company on a path to profitability. Meanwhile, the new cancer company would be an independent and publicly traded entity with a lead immunotherapy in pivotal testing for two types of cancer.

There needs to be a bigger emphasis and move towards connecting the life science companies who are doing the work of using biomarkers to develop therapies with the health systems where a majority of cancer care in the US actually occurs. Not enough patients are getting the benefit of precision medicine today. It starts with data sharing and real world evidence.